BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 50 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $14,321,000 | +6.8% | 11,891,000 | -1.1% | 1.10% | -3.7% |
| Q2 2016 | $13,415,000 | -52.1% | 12,025,000 | -50.1% | 1.15% | -55.8% |
| Q1 2016 | $28,030,000 | +47.8% | 24,099,000 | +63.7% | 2.60% | +37.3% |
| Q4 2015 | $18,959,000 | -0.9% | 14,717,000 | +0.6% | 1.89% | +2.5% |
| Q3 2015 | $19,122,000 | -21.1% | 14,632,000 | -6.2% | 1.84% | -20.9% |
| Q2 2015 | $24,224,000 | -5.8% | 15,597,000 | -10.5% | 2.33% | -18.8% |
| Q1 2015 | $25,704,000 | +8.3% | 17,422,000 | -13.5% | 2.87% | +9.1% |
| Q4 2014 | $23,724,000 | +40.1% | 20,148,000 | +26.2% | 2.63% | +37.0% |
| Q3 2014 | $16,929,000 | +298.9% | 15,970,000 | +289.5% | 1.92% | +283.4% |
| Q2 2014 | $4,244,000 | – | 4,100,000 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MACKAY SHIELDS LLC | 37,179,000 | $41,455,000 | 2.06% |
| LINDEN ADVISORS LP | 24,592,000 | $27,360,000 | 1.20% |
| SHENKMAN CAPITAL MANAGEMENT INC | 12,025,000 | $13,415,000 | 1.15% |
| Ferox Capital Management LP | 3,465,000 | $3,889,000 | 1.09% |
| OAKTREE CAPITAL MANAGEMENT LP | 44,823,000 | $49,860,000 | 0.90% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 40,514,000 | $45,097,000 | 0.70% |
| RWC Asset Management LLP | 7,500,000 | $8,322,000 | 0.53% |
| CSS LLC/IL | 4,196,000 | $4,653,000 | 0.31% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $2,231,000 | 0.24% |
| EDMOND DE ROTHSCHILD ASSET MANAGEMENT (FRANCE) | 3,750,000 | $4,176,000 | 0.19% |